Literature DB >> 9757973

Persistent abnormalities in plasma volume and renal hemodynamics in patients with a history of preeclampsia.

E van Beek1, T H Ekhart, P M Schiffers, J van Eyck, L L Peeters, P W de Leeuw.   

Abstract

OBJECTIVE: The objective was to test the hypothesis that women with a recent history of preeclampsia have abnormalities in renal hemodynamics and volume status. STUDY
DESIGN: We studied a group of 26 primiparous women with history of preeclampsia and a group of 12 parous women with a history of uneventful pregnancies (control group). At least 4 months post partum we compared the following variables between these groups: effective renal plasma flow, glomerular filtration rate, plasma volume, plasma concentration of active renin, plasma concentration of angiotensin II, plasma concentration of aldosterone, and plasma concentration of atrial natriuretic peptide.
RESULTS: Both plasma volume and plasma concentration of atrial natriuretic peptide were lower in the formerly preeclamptic group. Compared with the control subjects, the formerly preeclamptic group also had a lower effective renal plasma flow, a higher filtration fraction, and a higher renal vascular resistance. Intergroup differences in plasma concentration of active renin, plasma concentration of angiotensin II and plasma concentration of aldosterone were small and inconsistent.
CONCLUSIONS: Women with history of preeclampsia are relatively hypovolemic and tend to have lower effective renal plasma flow and higher renal vascular resistance and filtration fraction than do control subjects. These findings support the hypothesis that otherwise healthy women with a history of preeclampsia show abnormalities in their volume status and renal hemodynamics, irrespective of their blood pressure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757973     DOI: 10.1016/s0002-9378(98)70066-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia.

Authors:  Lauren Anton; Anthony O Olarerin-George; Nadav Schwartz; Sindhu Srinivas; Jamie Bastek; John B Hogenesch; Michal A Elovitz
Journal:  Am J Pathol       Date:  2013-09-10       Impact factor: 4.307

2.  Adrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia.

Authors:  Madhu Chauhan; Meena Balakrishnan; Alex Vidaeff; Uma Yallampalli; Fernando Lugo; Karin Fox; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2016-09-01       Impact factor: 5.958

Review 3.  Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy.

Authors:  Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-13       Impact factor: 3.619

4.  Maternal hemoglobin concentration and its association with birth weight in newborns of mothers with preeclampsia.

Authors:  Odül A Amburgey; Eliesa Ing; Gary J Badger; Ira M Bernstein
Journal:  J Matern Fetal Neonatal Med       Date:  2009-09

5.  Assessment of Correlation Between miR-210 Expression and Pre-Eclampsia Risk: A Meta-Analysis.

Authors:  Mehdi Koushki; Nasrin Amiri Dash Atan; Hossein Omidi-Ardali; Mostafa Rezaei Tavirani
Journal:  Rep Biochem Mol Biol       Date:  2018-10

6.  Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia.

Authors:  George W Booz; Daniel Kennedy; Michael Bowling; Taprieka Robinson; Daniel Azubuike; Brandon Fisher; Karen Brooks; Pooja Chinthakuntla; Ngoc H Hoang; Jonathan P Hosler; Mark W Cunningham
Journal:  Biol Sex Differ       Date:  2021-11-02       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.